![Enrique Poradosu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Enrique Poradosu
Grundare på
NUVECTIS PHARMA, INC.
Förmögenhet: 39 M $ per 2026-07-31
Profil
Enrique Poradosu is the founder of Nuvectis Pharma, Inc., founded in 2020, and holds the title of Executive VP, Chief Scientific & Business Officer.
Former jobs include Vice President-Business & Scientific Strategy at Keryx Biopharmaceuticals, Inc. from 2003 to 2016, and Senior VP-Business & Scientific Strategy at Stemline Therapeutics, Inc. from 2016 to 2020.
Education includes undergraduate and doctorate degrees from The Hebrew University of Jerusalem.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
NUVECTIS PHARMA, INC. 5,73 % | 2026-04-13 | 1 806 319 ( 5,73 % ) | 39 M $ | 2026-07-31 |
Aktiva positioner av Enrique Poradosu
| Företag | Position | Start |
|---|---|---|
| NUVECTIS PHARMA, INC. | Grundare | 2020-07-27 |
Tidigare kända positioner av Enrique Poradosu
| Företag | Position | Slut |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | Företagsledare/Principal | 2020-12-01 |
| KERYX BIOPHARMACEUTICALS | Teknisk/Vetenskaplig/F&U Direktör | 2016-01-01 |
Enrique Poradosus utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
51
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvectis Pharma, Inc.
 Nuvectis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer | Health Technology |
